|
1.
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Kim VN: MicroRNA biogenesis: coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Lawrie CH: MicroRNA expression in lymphoid
malignancies: new hope for diagnosis and therapy? Cell Mol Med.
12:1432–1444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Calin GA, Ferracin M, Cimmino A, et al: A
microRNA signature associated with prognosis and progression in
chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Lawrie CH, Gal S, Dunlop HM, et al:
Detection of elevated levels of tumour associated microRNAs in
serum of patients with diffuse large B-cell lymphoma. Br J
Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kota SK and Balasubramanian S: Cancer
therapy via modulation of microRNA levels: a promising future. Drug
Discov Today. 15:733–740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Coiffier B: Diffuse large cell lymphoma.
Curr Opin Oncol. 13:325–334. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Alizadeh AA, Eisen MB, Davis RE, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hans CP, Weisenburger DD, Greiner TC, et
al: Confirmation of the molecular classification of diffuse large
B-cell lymphoma by immunohistochemistry using a tissue microarray.
Blood. 103:275–282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Davis RE, Brown KD, Siebenlist U, et al:
Constitutive nuclear factor kappaB activity is required for
survival of activated B cell-like diffuse large B cell lymphoma
cells. J Exp Med. 194:1861–1874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Thompson RC, Herscovitch M, Zhao I, et al:
NF-kappaB down-regulates expression of the B-lymphoma marker CD10
through a miR-155/PU.1 pathway. J Biol Chem. 286:1675–1682. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Braun T, Carvalho G, Fabre C, et al:
Targeting NF-kappaB in hematologic malignancies. Cell Death Differ.
13:748–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Taganov KD, Boldin MP, Chang KJ, et al:
NF-kappaB dependent induction of microRNA miR-146, an inhibitor
targeted to signaling proteins of innate immune responses. Proc
Natl Acad Sci USA. 103:12481–12486. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Li J, Smyth P, Flavin R, et al: Comparison
of miRNA expression patterns using total RNA extracted from matched
samples of formalin-fixed paraffin-embedded (FFPE) cells and snap
frozen cells. BMC Biotechnol. 7:362007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lawrie CH, Soneji S, Marafioti T, et al:
MicroRNA expression distinguishes between germinal center B
cell-like and activated B cell-like subtypes of diffuse large B
cell lymphoma. Int J Cancer. 121:1156–1161. 2007. View Article : Google Scholar
|
|
17.
|
Nogai H, Dörken B and Lenz GJ:
Pathogenesis of non-Hodgkin’s lymphoma. Clin Oncol. 29:1803–1811.
2011.
|
|
18.
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantificiation of microRNAs by stem-loop RT-PCR.
Nucletic Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar
|
|
23.
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lawrie CH, Saunders NJ, Soneji S, et al:
MicroRNA expression in lymphocyte development and malignancy.
Leukemia. 22:1440–1446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lawrie CH, Chi JX, Taylor S, et al:
Expression of microRNAs in diffuse large B cell lymphoma is
associated with immunophenotype, survival and transformation from
follicular lymphoma. J Cell Mol Med. 13:1248–1260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Xi Y, Nakajima G, Gavin E, et al:
Systematic analysis of microRNA expression of RNA extracted from
fresh frozen and formalin-fixed paraffin-embedded samples. RNA.
13:1668–1674. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Georgantas RW III, Hildreth R, Morisot S,
et al: CD34+ hematopoietic stem-progenitor cell microRNA
expression and function: a circuit diagram of differentiation
control. Proc Natl Acad Sci USA. 104:2750–2755. 2007.PubMed/NCBI
|
|
28.
|
Eis PS, Tam W, Sun L, et al: Accumulation
of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad
Sci USA. 102:3627–3632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Kluiver J, Poppema S, de Jong D, et al:
BIC and miR-155 are highly expressed in Hodgkin, primary
mediastinal and diffuse large B cell lymphomas. J Pathol.
207:243–249. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Chang TC, Yu D, Lee YS, et al: Widespread
microRNA repression by Myc contributes to tumorigenesis. Nat Genet.
40:43–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Zhang H, Luo XQ, Zhang P, et al: MicroRNA
patterns associated with clinical prognostic parameters and CNS
relapse prediction in pediatric acute leukemia. PLoS One.
4:e78262009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Wang Y, Li Z, He C, et al: MicroRNA
expression signatures are associated with lineage and survival in
acute leukemias. Blood Cells Mol Dis. 44:191–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Visone R, Rassenti LZ, Veronese A, et al:
Karyotype-specific microRNA signature in chronic lymphocytic
leukemia. Blood. 114:3872–3879. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Roldo C, Missiaglia E, Hagan JP, et al:
MicroRNA expression abnormalities in pancreatic endocrine and
acinar tumors are associated with distinctive pathologic features
and clinical behavior. J Clin Oncol. 24:4677–4684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Volinia S, Galasso M, Costinean S, et al:
Reprogramming of miRNA networks in cancer and leukemia. Genome Res.
20:589–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Monticelli S, Ansel KM, Xiao C, et al:
MicroRNA profiling of the murine hematopoietic system. Genome Biol.
6:R712005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Boominathan L: The guardians of the genome
(p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNA
network. Cancer Metastasis Rev. 29:613–639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Thai TH, Calado DP, Casola S, et al:
Regulation of the germinal center response by microRNA-155.
Science. 316:604–608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Costinean S, Zanesi N, Pekarsky Y, et al:
Pre-B cell proliferation and lymphoblastic leukemia/highgrade
lymphoma in E (mu)-miR155 transgenic mice. Proc Natl Acad Sci USA.
103:7024–7029. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Boldin MP, Taganov KD, Rao DS, et al:
miR-146a is a significant brake on autoimmunity,
myeloproliferation, and cancer in mice. J Exp Med. 208:1189–1201.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Lenz G, Wright GW, Emre NCT, et al:
Molecular subtypes of diffuse large B-cell lymphoma arise by
distinct genetic pathways. Proc Natl Acad Sci USA. 105:13520–13525.
2008. View Article : Google Scholar : PubMed/NCBI
|
